Cyclosporine eye emulsion
قطره چشمی سیکلوسپورین
👁️ Sensory OrgansOphthalmic immunomodulator
Market / country: 🇺🇸 USA
Restasis (US)
🧮 Dose calculator
Dry eye · Regimen source: FDA Restasis · 2.2
- • About 12 h apart; 15 min apart from artificial tears. Do not touch the bottle tip to the eye. FDA Restasis · 2.1FDA Restasis · 5.1
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Known or suspected hypersensitivity to any ingredient. FDA Restasis · 4
Formulations
- Cyclosporine 0.05% ophthalmic emulsion — eye drops 🇺🇸 USA FDA Restasis · 3
👥 Special populations
- 🤰 PregnancyNo specific problem stated
Label: minimal systemic absorption; fetal exposure not expected. FDA Restasis · 8.1
“… detected systemically following topical ocular administration [see Clinical Pharmacology (12.3) ] , and maternal use is not expected to result in fetal exposure to the drug.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Restasis · 8.2
“Although blood concentrations are undetectable following topical administration of cyclosporine ophthalmic emulsion 0.05% [see Clinical Pharmacology (12.3) ] , caution should be exercised when RESTASIS MULTIDOSE is administered to a nursing woman.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Restasis · 8.4
“Safety and efficacy have not been established in pediatric patients below the age of 16.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Restasis · 8.5
“No overall difference in safety or effectiveness has been observed between elderly and younger patients.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA050790
- DailyMed (FDA label)FDA Restasis
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDS01XA18
- Darooyab (Iran)Ciclosporin
🇮🇷 Registered in Iran Darooyab · G-2733/Ciclosporin
Dosage forms with Iranian generic codes, per Darooyab.
- 06815 · CICLOSPORIN 0.05% OPH DROP · قطره چشمی سیکلوسپورین ۰٫۰۵ درصد
- 00287 · CICLOSPORIN 100MG CAP · کپسول سیکلوسپورین ۱۰۰ میلیگرم
- 06685 · CICLOSPORIN 250MG/5ML AMP · آمپول سیکلوسپورین ۲۵۰ میلیگرم / ۵ میلیلیتر
- 00288 · CICLOSPORIN 25MG CAP · کپسول سیکلوسپورین ۲۵ میلیگرم
- 01758 · CICLOSPORIN 50MG CAP · کپسول سیکلوسپورین ۵۰ میلیگرم
- 01452 · CICLOSPORIN 50MG/1ML AMP · آمپول سیکلوسپورین ۵۰ میلیگرم / ۱ میلیلیتر
- 00289 · CICLOSPORIN I00MG/ML 50ML ORAL SOL · محلول سیکلوسپورین ید ۰۰ میلیگرم / میلیلیتر ۵۰ میلیلیتر
- 52168 · CYCLOSPORIN SOLUTION, DROPS OPHTHALMIC 0.05 % 0.4 mL · قطره چشمی سیکلوسپورین ۰٫۰۵ درصد ۰٫۴ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Restasis · 3FDA Restasis · 2.2FDA Restasis · 2.1FDA Restasis · 5.1FDA Restasis · 4FDA Restasis · 8.1FDA Restasis · 8.2FDA Restasis · 8.4FDA Restasis · 8.5FDA Restasis · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2733/Ciclosporin
- Clinical review⚠ Unverified